+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Covid-19 Vaccination Market 2023-2027

  • PDF Icon

    Report

  • 156 Pages
  • October 2023
  • Region: Global
  • TechNavio
  • ID: 5504938
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The covid-19 vaccination market is forecasted to grow by USD -54598.89 million during 2022-2027, accelerating at a CAGR of -29.3% during the forecast period. The report on the covid-19 vaccination market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of vaccination programs, emergence of new covid-19 variants, and expanded covid-19 vaccine eligibility.

The covid-19 vaccination market is segmented as below:

By Type

  • mRNA
  • Others

By Distribution Channel

  • Government entities
  • Hospitals and clinics
  • Others

By Geographical Landscape

  • North America
  • Asia
  • Europe
  • Rest of World (ROW)
This study identifies the rising r and d investment as one of the prime reasons driving the covid-19 vaccination market growth during the next few years. Also, launch of new covid-19 vaccines and adoption of technology and innovation in covid-19 vaccination market will lead to sizable demand in the market.

The report on the covid-19 vaccination market covers the following areas:

  • Covid-19 vaccination market sizing
  • Covid-19 vaccination market forecast
  • Covid-19 vaccination market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading covid-19 vaccination market vendors that include AIVITA Biomedical Inc., AnGes Inc., AstraZeneca Plc, Bharat Biotech Ltd., CureVac AG, Emergent BioSolutions Inc., Eubiologics Co. Ltd., Genexine Inc., GreenLight Biosciences Holdings PBC, Inovio Pharmaceuticals Inc., Johnson and Johnson, Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., Tadbir innovation pharmaceutical Co., The Gamaleya National Center, and Zydus Lifesciences Ltd.. Also, the covid-19 vaccination market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary €“ Chart on Market Overview
Exhibit 02: Executive Summary €“ Data Table on Market Overview
Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type
Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary €“ Chart on Incremental Growth
Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
4.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
4.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
4.4 Threat of new entrants
Exhibit 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
4.5 Threat of substitutes
Exhibit 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
4.6 Threat of rivalry
Exhibit 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
4.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
5 Market Segmentation by Type
5.1 Market segments
Exhibit 25: Chart on Type - Market share 2022-2027 (%)
Exhibit 26: Data Table on Type - Market share 2022-2027 (%)
5.2 Comparison by Type
Exhibit 27: Chart on Comparison by Type
Exhibit 28: Data Table on Comparison by Type
5.3 mRNA - Market size and forecast 2022-2027
Exhibit 29: Chart on mRNA - Market size and forecast 2022-2027 ($ million)
Exhibit 30: Data Table on mRNA - Market size and forecast 2022-2027 ($ million)
Exhibit 31: Chart on mRNA - Year-over-year growth 2022-2027 (%)
Exhibit 32: Data Table on mRNA - Year-over-year growth 2022-2027 (%)
5.4 Others - Market size and forecast 2022-2027
Exhibit 33: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 34: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Others - Year-over-year growth 2022-2027 (%)
5.5 Market opportunity by Type
Exhibit 37: Market opportunity by Type ($ million)
Exhibit 38: Data Table on Market opportunity by Type ($ million)
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 39: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 40: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 41: Chart on Comparison by Distribution Channel
Exhibit 42: Data Table on Comparison by Distribution Channel
6.3 Government entities - Market size and forecast 2022-2027
Exhibit 43: Chart on Government entities - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Data Table on Government entities - Market size and forecast 2022-2027 ($ million)
Exhibit 45: Chart on Government entities - Year-over-year growth 2022-2027 (%)
Exhibit 46: Data Table on Government entities - Year-over-year growth 2022-2027 (%)
6.4 Hospitals and clinics - Market size and forecast 2022-2027
Exhibit 47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 55: Market opportunity by Distribution Channel ($ million)
Exhibit 56: Data Table on Market opportunity by Distribution Channel ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Exhibit 58: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 59: Data Table on Market share By Geographical Landscape 2022-2027 (%)
8.2 Geographic comparison
Exhibit 60: Chart on Geographic comparison
Exhibit 61: Data Table on Geographic comparison
8.3 North America - Market size and forecast 2022-2027
Exhibit 62: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 65: Data Table on North America - Year-over-year growth 2022-2027 (%)
8.4 Asia - Market size and forecast 2022-2027
Exhibit 66: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 69: Data Table on Asia - Year-over-year growth 2022-2027 (%)
8.5 Europe - Market size and forecast 2022-2027
Exhibit 70: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 73: Data Table on Europe - Year-over-year growth 2022-2027 (%)
8.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 74: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 77: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
8.7 US - Market size and forecast 2022-2027
Exhibit 78: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 81: Data Table on US - Year-over-year growth 2022-2027 (%)
8.8 China - Market size and forecast 2022-2027
Exhibit 82: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 85: Data Table on China - Year-over-year growth 2022-2027 (%)
8.9 Japan - Market size and forecast 2022-2027
Exhibit 86: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 89: Data Table on Japan - Year-over-year growth 2022-2027 (%)
8.10 UK - Market size and forecast 2022-2027
Exhibit 90: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 93: Data Table on UK - Year-over-year growth 2022-2027 (%)
8.11 Germany - Market size and forecast 2022-2027
Exhibit 94: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 97: Data Table on Germany - Year-over-year growth 2022-2027 (%)
8.12 Market opportunity By Geographical Landscape
Exhibit 98: Market opportunity By Geographical Landscape ($ million)
Exhibit 99: Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 100: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends
10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
Exhibit 101: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 102: Overview on factors of disruption
10.4 Industry risks
Exhibit 103: Impact of key risks on business
11 Vendor Analysis
11.1 Vendors covered
Exhibit 104: Vendors covered
11.2 Market positioning of vendors
Exhibit 105: Matrix on vendor position and classification
11.3 AstraZeneca Plc
Exhibit 106: AstraZeneca Plc - Overview
Exhibit 107: AstraZeneca Plc - Product/Service
Exhibit 108: AstraZeneca Plc - Key news
Exhibit 109: AstraZeneca Plc - Key offerings
11.4 Bharat Biotech Ltd.
Exhibit 110: Bharat Biotech Ltd. - Overview
Exhibit 111: Bharat Biotech Ltd. - Product/Service
Exhibit 112: Bharat Biotech Ltd. - Key news
Exhibit 113: Bharat Biotech Ltd. - Key offerings
11.5 CureVac AG
Exhibit 114: CureVac AG - Overview
Exhibit 115: CureVac AG - Key offerings
11.6 Emergent BioSolutions Inc.
Exhibit 116: Emergent BioSolutions Inc. - Overview
Exhibit 117: Emergent BioSolutions Inc. - Product/Service
Exhibit 118: Emergent BioSolutions Inc. - Key news
Exhibit 119: Emergent BioSolutions Inc. - Key offerings
11.7 Genexine Inc.
Exhibit 120: Genexine Inc. - Overview
Exhibit 121: Genexine Inc. - Product/Service
Exhibit 122: Genexine Inc. - Key offerings
11.8 Inovio Pharmaceuticals Inc.
Exhibit 123: Inovio Pharmaceuticals Inc. - Overview
Exhibit 124: Inovio Pharmaceuticals Inc. - Product/Service
Exhibit 125: Inovio Pharmaceuticals Inc. - Key news
Exhibit 126: Inovio Pharmaceuticals Inc. - Key offerings
11.9 Johnson and Johnson
Exhibit 127: Johnson and Johnson - Overview
Exhibit 128: Johnson and Johnson - Business segments
Exhibit 129: Johnson and Johnson - Key news
Exhibit 130: Johnson and Johnson - Key offerings
Exhibit 131: Johnson and Johnson - Segment focus
11.10 Moderna Inc.
Exhibit 132: Moderna Inc. - Overview
Exhibit 133: Moderna Inc. - Product/Service
Exhibit 134: Moderna Inc. - Key offerings
11.11 Novavax Inc.
Exhibit 135: Novavax Inc. - Overview
Exhibit 136: Novavax Inc. - Product/Service
Exhibit 137: Novavax Inc. - Key offerings
11.12 Pfizer Inc.
Exhibit 138: Pfizer Inc. - Overview
Exhibit 139: Pfizer Inc. - Product/Service
Exhibit 140: Pfizer Inc. - Key news
Exhibit 141: Pfizer Inc. - Key offerings
11.13 Serum Institute of India Pvt. Ltd.
Exhibit 142: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 143: Serum Institute of India Pvt. Ltd. - Product/Service
Exhibit 144: Serum Institute of India Pvt. Ltd. - Key offerings
11.14 Shenzhen Kangtai Biological Products Co. Ltd.
Exhibit 145: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibit 146: Shenzhen Kangtai Biological Products Co. Ltd. - Product/Service
Exhibit 147: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
11.15 Sinovac Biotech Ltd.
Exhibit 148: Sinovac Biotech Ltd. - Overview
Exhibit 149: Sinovac Biotech Ltd. - Product/Service
Exhibit 150: Sinovac Biotech Ltd. - Key offerings
11.16 Tadbir innovation pharmaceutical Co.
Exhibit 151: Tadbir innovation pharmaceutical Co. - Overview
Exhibit 152: Tadbir innovation pharmaceutical Co. - Product/Service
Exhibit 153: Tadbir innovation pharmaceutical Co. - Key offerings
11.17 Zydus Lifesciences Ltd.
Exhibit 154: Zydus Lifesciences Ltd. - Overview
Exhibit 155: Zydus Lifesciences Ltd. - Business segments
Exhibit 156: Zydus Lifesciences Ltd. - Key offerings
Exhibit 157: Zydus Lifesciences Ltd. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 158: Inclusions checklist
Exhibit 159: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 160: Currency conversion rates for US$
12.4 Research methodology
Exhibit 161: Research methodology
Exhibit 162: Validation techniques employed for market sizing
Exhibit 163: Information sources
12.5 List of abbreviations
Exhibit 164: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary €“ Chart on Market Overview
Exhibits 2: Executive Summary €“ Data Table on Market Overview
Exhibits 3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits 4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits 6: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary €“ Chart on Incremental Growth
Exhibits 8: Executive Summary €“ Data Table on Incremental Growth
Exhibits 9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Five forces analysis - Comparison between 2022 and 2027
Exhibits 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits 24: Chart on Market condition - Five forces 2022 and 2027
Exhibits 25: Chart on Type - Market share 2022-2027 (%)
Exhibits 26: Data Table on Type - Market share 2022-2027 (%)
Exhibits 27: Chart on Comparison by Type
Exhibits 28: Data Table on Comparison by Type
Exhibits 29: Chart on mRNA - Market size and forecast 2022-2027 ($ million)
Exhibits 30: Data Table on mRNA - Market size and forecast 2022-2027 ($ million)
Exhibits 31: Chart on mRNA - Year-over-year growth 2022-2027 (%)
Exhibits 32: Data Table on mRNA - Year-over-year growth 2022-2027 (%)
Exhibits 33: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 34: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 36: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 37: Market opportunity by Type ($ million)
Exhibits 38: Data Table on Market opportunity by Type ($ million)
Exhibits 39: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 40: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 41: Chart on Comparison by Distribution Channel
Exhibits 42: Data Table on Comparison by Distribution Channel
Exhibits 43: Chart on Government entities - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Data Table on Government entities - Market size and forecast 2022-2027 ($ million)
Exhibits 45: Chart on Government entities - Year-over-year growth 2022-2027 (%)
Exhibits 46: Data Table on Government entities - Year-over-year growth 2022-2027 (%)
Exhibits 47: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 55: Market opportunity by Distribution Channel ($ million)
Exhibits 56: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 58: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 59: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 60: Chart on Geographic comparison
Exhibits 61: Data Table on Geographic comparison
Exhibits 62: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 63: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 65: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 66: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 69: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 70: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 73: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 77: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 78: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 81: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 82: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 85: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 86: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 89: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 90: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 93: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 94: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 97: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 98: Market opportunity By Geographical Landscape ($ million)
Exhibits 99: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 100: Impact of drivers and challenges in 2022 and 2027
Exhibits 101: Overview on Criticality of inputs and Factors of differentiation
Exhibits 102: Overview on factors of disruption
Exhibits 103: Impact of key risks on business
Exhibits 104: Vendors covered
Exhibits 105: Matrix on vendor position and classification
Exhibits 106: AstraZeneca Plc - Overview
Exhibits 107: AstraZeneca Plc - Product/Service
Exhibits 108: AstraZeneca Plc - Key news
Exhibits 109: AstraZeneca Plc - Key offerings
Exhibits 110: Bharat Biotech Ltd. - Overview
Exhibits 111: Bharat Biotech Ltd. - Product/Service
Exhibits 112: Bharat Biotech Ltd. - Key news
Exhibits 113: Bharat Biotech Ltd. - Key offerings
Exhibits 114: CureVac AG - Overview
Exhibits 115: CureVac AG - Key offerings
Exhibits 116: Emergent BioSolutions Inc. - Overview
Exhibits 117: Emergent BioSolutions Inc. - Product/Service
Exhibits 118: Emergent BioSolutions Inc. - Key news
Exhibits 119: Emergent BioSolutions Inc. - Key offerings
Exhibits 120: Genexine Inc. - Overview
Exhibits 121: Genexine Inc. - Product/Service
Exhibits 122: Genexine Inc. - Key offerings
Exhibits 123: Inovio Pharmaceuticals Inc. - Overview
Exhibits 124: Inovio Pharmaceuticals Inc. - Product/Service
Exhibits 125: Inovio Pharmaceuticals Inc. - Key news
Exhibits 126: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits 127: Johnson and Johnson - Overview
Exhibits 128: Johnson and Johnson - Business segments
Exhibits 129: Johnson and Johnson - Key news
Exhibits 130: Johnson and Johnson - Key offerings
Exhibits 131: Johnson and Johnson - Segment focus
Exhibits 132: Moderna Inc. - Overview
Exhibits 133: Moderna Inc. - Product/Service
Exhibits 134: Moderna Inc. - Key offerings
Exhibits 135: Novavax Inc. - Overview
Exhibits 136: Novavax Inc. - Product/Service
Exhibits 137: Novavax Inc. - Key offerings
Exhibits 138: Pfizer Inc. - Overview
Exhibits 139: Pfizer Inc. - Product/Service
Exhibits 140: Pfizer Inc. - Key news
Exhibits 141: Pfizer Inc. - Key offerings
Exhibits 142: Serum Institute of India Pvt. Ltd. - Overview
Exhibits 143: Serum Institute of India Pvt. Ltd. - Product/Service
Exhibits 144: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits 145: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibits 146: Shenzhen Kangtai Biological Products Co. Ltd. - Product/Service
Exhibits 147: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
Exhibits 148: Sinovac Biotech Ltd. - Overview
Exhibits 149: Sinovac Biotech Ltd. - Product/Service
Exhibits 150: Sinovac Biotech Ltd. - Key offerings
Exhibits 151: Tadbir innovation pharmaceutical Co. - Overview
Exhibits 152: Tadbir innovation pharmaceutical Co. - Product/Service
Exhibits 153: Tadbir innovation pharmaceutical Co. - Key offerings
Exhibits 154: Zydus Lifesciences Ltd. - Overview
Exhibits 155: Zydus Lifesciences Ltd. - Business segments
Exhibits 156: Zydus Lifesciences Ltd. - Key offerings
Exhibits 157: Zydus Lifesciences Ltd. - Segment focus
Exhibits 158: Inclusions checklist
Exhibits 159: Exclusions checklist
Exhibits 160: Currency conversion rates for US$
Exhibits 161: Research methodology
Exhibits 162: Validation techniques employed for market sizing
Exhibits 163: Information sources
Exhibits 164: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global covid-19 vaccination market: AIVITA Biomedical Inc., AnGes Inc., AstraZeneca Plc, Bharat Biotech Ltd., CureVac AG, Emergent BioSolutions Inc., Eubiologics Co. Ltd., Genexine Inc., GreenLight Biosciences Holdings PBC, Inovio Pharmaceuticals Inc., Johnson and Johnson, Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., Tadbir innovation pharmaceutical Co., The Gamaleya National Center, and Zydus Lifesciences Ltd..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising R and D investment.'

According to the report, one of the major drivers for this market is the expansion of vaccination programs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AIVITA Biomedical Inc.
  • AnGes Inc.
  • AstraZeneca Plc
  • Bharat Biotech Ltd.
  • CureVac AG
  • Emergent BioSolutions Inc.
  • Eubiologics Co. Ltd.
  • Genexine Inc.
  • GreenLight Biosciences Holdings PBC
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson
  • Moderna Inc.
  • Novavax Inc.
  • Pfizer Inc.
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.
  • Sinovac Biotech Ltd.
  • Tadbir innovation pharmaceutical Co.
  • The Gamaleya National Center
  • Zydus Lifesciences Ltd.